The illicit opioid supply continues to evolve. Fentanyl remains a major driver of overdose risk, but federal authorities are now warning about additional synthetic substances being detected alongside it, including an unfamiliar opioid called cychlorphine.
Cychlorphine, also known as N-propionitrile chlorphine, is a highly potent synthetic opioid in the emerging “orphine” class. It has been detected in the U.S. illicit drug supply and linked with fatal overdoses, including a significant cluster in Tennessee. In August 2026, the DEA temporarily placed cychlorphine in Schedule I under its emergency scheduling authority.
The concern is not simply that another opioid has appeared. The larger problem is an increasingly unpredictable illicit drug supply in which a person may not know what substances, concentrations, or combinations are present in a powder or counterfeit pill.
For individuals and families in Tennessee and Kentucky, understanding emerging opioids such as cychlorphine can help explain why overdose risk may change even when someone believes they are using the same drug they have used before.
What Is Cychlorphine?
Cychlorphine is a synthetic opioid that has emerged in the illicit drug market. It is also known as N-propionitrile chlorphine and belongs to the orphine analogue class of synthetic opioids.
Unlike prescription opioids manufactured for an approved medical purpose, cychlorphine has no approved medical use in the United States and is encountered in the illicit drug supply. The DEA temporarily placed it in Schedule I in August 2026.
Laboratory and public-health reporting have associated cychlorphine with severe opioid toxicity and fatal overdoses. Tennessee health officials reported more than 30 fatal overdoses statewide associated with cychlorphine from October 2025 through March 2026.
This matters because someone exposed to cychlorphine may never have intentionally sought it out. It may appear in an illicit opioid product, fentanyl powder, or another unregulated drug mixture without the person’s knowledge.
Why Is Cychlorphine Emerging in the U.S. Drug Supply?
The illicit drug market is continuously changing. When enforcement efforts, scheduling actions, availability, price, or supply chains change, new synthetic substances can appear.
Cychlorphine is part of a broader wave of novel synthetic substances appearing in the illicit drug market. It has been detected both with other drugs and as the only opioid identified in some fatal toxicology cases, so it should not be described solely as a fentanyl adulterant.
These substances are not all pharmacologically identical. Xylazine and medetomidine are non-opioid veterinary sedatives, while nitazenes and cychlorphine are synthetic opioids.
That distinction is clinically important because different substances can produce different effects and may respond differently during an overdose.
Cychlorphine vs. Fentanyl
Both substances are synthetic opioids, but they should not be treated as interchangeable.
Illicit Fentanyl
Fentanyl is a synthetic opioid that also has legitimate medical uses when prescribed and administered appropriately. Most current fentanyl-related overdose harm is associated with illegally manufactured fentanyl entering the illicit drug supply.
Cychlorphine
Cychlorphine is an emerging unregulated synthetic opioid identified by federal authorities in the illicit drug environment. Someone exposed to it may not know the substance is present.
The practical concern is not deciding which drug is “worse.” It is recognizing that an illicit opioid product can contain more than one potent opioid and that its composition may change from one batch or pill to another.
How Potent Is Cychlorphine?
Public information about cychlorphine remains more limited than information available for established opioids such as fentanyl, heroin, or oxycodone.
Current laboratory and public-health sources describe cychlorphine as approximately 10 times more potent than fentanyl in laboratory pharmacology data. Tennessee health officials have used the same comparison in public-health messaging.
That estimate should not be interpreted as a dosing guide. Laboratory potency does not create a predictable “safe” amount in illicit products, where concentration, purity, route of exposure, tolerance, and the presence of other substances can vary substantially.
Potency is only part of the problem. An individual may also be exposed to multiple opioids or other sedating substances at the same time.
Why Cychlorphine May Be Found With Fentanyl
DEA’s warning reflects a broader problem in the illicit drug supply: people may be exposed to multiple substances without intentionally combining them.
Illicitly manufactured fentanyl is frequently sold as powder or pressed into counterfeit pills. Additional synthetic drugs can enter those products during manufacturing, distribution, or intentional formulation.
As a result, someone may believe they are using fentanyl while being exposed to cychlorphine or another opioid as well.
This kind of unintentional polysubstance exposure can make the effects of a familiar-looking product dramatically less predictable.
Cychlorphine and Counterfeit Pills
Counterfeit prescription pills are a major part of the modern overdose landscape. Illicit tablets can be manufactured to resemble familiar medications while containing entirely different substances.
Appearance Is Not Reliable
A pill’s color, shape, imprint, or packaging cannot reliably establish what it contains when it did not come from a licensed pharmacy.
Potency Can Vary
Unregulated pills may contain inconsistent concentrations, creating substantially different effects from one tablet to another.
More Than One Drug May Be Present
Counterfeit pills may expose a person to fentanyl, another opioid, sedatives, stimulants, or several substances at once.
Unexpected Exposure
A person may experience an opioid overdose without realizing the product contained a potent synthetic opioid.
Signs of a Synthetic Opioid Overdose
Cychlorphine is an opioid, so a serious exposure may produce signs associated with opioid poisoning and respiratory depression.
Slow or Abnormal Breathing
Breathing may become very slow, shallow, irregular, or stop entirely.
Unable to Wake
The person may be unconscious or fail to respond to voice, touch, or attempts to wake them.
Extreme Sedation
Someone may appear unusually sleepy, limp, or unable to remain awake.
Color Changes
Lips, fingertips, or skin may appear pale, gray, or bluish when oxygen levels are dangerously low.
Does Naloxone Work on Cychlorphine?
Because cychlorphine is an opioid, naloxone can counter opioid effects during an overdose.
Tennessee health officials report that naloxone is effective for cychlorphine overdose, although repeat dosing may be necessary if the person does not respond or breathing slows again.
This is different from non-opioid adulterants such as xylazine or medetomidine. Naloxone does not directly reverse those substances, although it should still be given during a suspected overdose because opioids may also be present.
A person who begins responding to naloxone still needs emergency medical evaluation. Naloxone’s effects can wear off while potent opioids remain active.
Why New Synthetic Opioids Are Difficult to Detect
One of the challenges surrounding emerging synthetic opioids is that the drug supply may change faster than public awareness, routine testing, and treatment systems can adapt.
Someone seeking care may truthfully report using “fentanyl,” “heroin,” or a counterfeit pain pill without knowing another opioid was present.
Routine toxicology testing also does not necessarily identify every emerging substance. Specialized testing may be necessary to identify uncommon synthetic opioids.
For treatment purposes, clinicians therefore consider more than a single drug-test result. Substance-use history, symptoms, withdrawal patterns, overdose history, physical examination, and known local drug-supply concerns can all contribute to assessment.
Dependence and Withdrawal From Synthetic Opioids
Repeated opioid exposure can lead to tolerance and physical dependence. When someone has become dependent, suddenly reducing or stopping opioid use can cause withdrawal.
Because cychlorphine is relatively new in the illicit drug supply, detailed human withdrawal data remain limited. Clinicians may therefore evaluate symptoms within the broader context of synthetic-opioid dependence and the other drugs involved.
Body Aches
Muscle and joint discomfort can occur as opioid effects wear off.
Restlessness and Anxiety
Agitation, anxiety, irritability, and an inability to settle down may occur.
Gastrointestinal Symptoms
Nausea, vomiting, diarrhea, abdominal discomfort, and loss of appetite can occur.
Sweating and Temperature Changes
Sweating, chills, goosebumps, and temperature discomfort are common opioid-withdrawal complaints.
Cravings and Sleep Problems
Intense cravings and insomnia can make early recovery particularly difficult.
Withdrawal can also become more complicated when fentanyl, benzodiazepines, alcohol, stimulants, or other drugs are being used at the same time.
Medical Detox for Synthetic Opioid Dependence
Someone struggling with fentanyl or another potent synthetic opioid may benefit from professional assessment to determine whether medical detoxification is appropriate.
Detox focuses on withdrawal management, stabilization, medical observation, symptom control, and preparation for continued addiction treatment.
This can be especially important when the individual is uncertain what substances were present in the products they were using.
At Tulip Hill Healthcare, individuals and families can access a continuum of care through treatment programs in Tennessee and Kentucky. Recommendations are based on substance use, withdrawal history, medical and mental health needs, and the level of structure required for recovery.
Synthetic Opioid Addiction Treatment in Tennessee and Kentucky
Detoxification can help someone move through withdrawal, but opioid addiction treatment usually extends beyond physical stabilization.
Continued treatment can help individuals understand triggers, manage cravings, address co-occurring mental health symptoms, strengthen coping skills, repair relationships, and develop a realistic plan for preventing relapse.
Depending on clinical needs, care may include residential addiction treatment, partial hospitalization, intensive outpatient treatment, outpatient services, medication support when clinically appropriate, individual therapy, group counseling, trauma-informed treatment, and continuing care.
Tulip Hill Healthcare connects individuals and families with addiction-treatment options throughout Tennessee and Kentucky, allowing the recommended level of care to be based on the person rather than simply the name of the drug involved.
Cychlorphine and Polysubstance Use
The appearance of cychlorphine should be understood as part of a broader shift toward an increasingly complex drug supply.
CDC describes polysubstance exposure as the presence or use of more than one drug, whether the combination is intentional or occurs without the person’s knowledge.
A person using fentanyl may also encounter another synthetic opioid. Someone taking a counterfeit pill may unknowingly receive fentanyl along with other drugs. Others intentionally combine opioids with stimulants, alcohol, or sedatives.
These combinations can change overdose risk, withdrawal symptoms, and treatment needs.
What Families Should Know About an Evolving Drug Supply
Families do not need to memorize the name of every emerging synthetic drug to recognize when someone may need help.
More useful warning signs include repeated overdose events, increasingly frequent opioid use, withdrawal between doses, unsuccessful attempts to stop, using alone, switching to counterfeit pills, combining substances, or needing opioids simply to avoid feeling sick.
If your loved one says they use fentanyl, do not assume that fentanyl is necessarily the only substance involved. Likewise, a person may be exposed to an emerging synthetic opioid without knowing its name.
A comprehensive clinical assessment can help determine what immediate risks need to be addressed and what level of treatment may be appropriate.
Frequently Asked Questions About Cychlorphine
What is cychlorphine?
Cychlorphine, also known as N-propionitrile chlorphine, is a highly potent synthetic opioid in the orphine analogue class. It has been detected in the illicit drug supply and linked with fatal overdoses.
Is it cychlorphine or cyclorphine?
Current public-health and international drug-monitoring sources commonly use “cychlorphine” and “N-propionitrile chlorphine.” Some forensic sources list additional spelling variants, so more than one form may appear in search results.
Is cychlorphine an opioid?
Yes. Cychlorphine is a potent synthetic opioid. The DEA temporarily placed it in Schedule I in August 2026.
Is cychlorphine the same as fentanyl?
Is cychlorphine stronger than fentanyl?
Laboratory and Tennessee public-health sources describe cychlorphine as approximately 10 times more potent than fentanyl. That figure is based on pharmacology data and should not be interpreted as a human dosing conversion or a predictable measure of risk in an illicit product.
Can cychlorphine be found in counterfeit pills?
DEA warns that emerging synthetic drugs can be hidden in counterfeit pills and fentanyl powder. Counterfeit pills should never be assumed to contain only the medication they resemble.
Does naloxone work on cychlorphine?
Yes. Tennessee health officials state that naloxone is effective for cychlorphine overdose. Repeat dosing may be needed if the person does not respond or breathing slows again, and emergency medical care is still necessary.
Should I call 911 after giving naloxone?
Yes. A suspected opioid overdose is a medical emergency. Call 911 immediately, administer naloxone if available, and continue following emergency-response instructions.
Can someone become dependent on synthetic opioids?
Repeated opioid exposure can lead to tolerance and physical dependence. Someone who experiences withdrawal, cravings, or difficulty stopping may benefit from a professional addiction assessment.
What does synthetic opioid withdrawal feel like?
Symptoms can include body aches, anxiety, restlessness, sweating, gastrointestinal discomfort, insomnia, cravings, and other opioid-withdrawal symptoms. Individual experiences vary, particularly when multiple substances are involved.
Can Tulip Hill Healthcare help with fentanyl or synthetic opioid addiction?
Tulip Hill Healthcare helps individuals and families access addiction treatment in Tennessee and Kentucky based on substance use, withdrawal concerns, mental health needs, and recommended level of care.
What treatment may be needed after opioid detox?
Depending on clinical needs, treatment may continue through residential care, PHP, IOP, outpatient services, medication support when appropriate, behavioral therapies, dual-diagnosis care, and ongoing relapse-prevention planning.
Clinical Sources and References
Medical and Clinical Review
Board-Certified Psychiatrist and Addictionologist
Licensed Clinical Social Worker
Get Help for Synthetic Opioid Addiction in Tennessee and Kentucky
You do not need to know every substance contained in an illicit pill or powder before asking for help.
If fentanyl, heroin, counterfeit pills, cychlorphine, prescription opioids, or other substances have become difficult to stop, Tulip Hill Healthcare can help you explore treatment options based on your individual needs.
Our network provides access to addiction treatment across Tennessee and Kentucky, including detox, residential treatment, outpatient levels of care, dual-diagnosis treatment, and continued recovery support.
Medically Reviewed By:
Dr. Vahid Osman, M.D.Board-Certified Psychiatrist and Addictionologist
Dr. Vahid Osman is a Board-Certified Psychiatrist and Addictionologist who has extensive experience in skillfully treating patients with mental illness, chemical dependency and developmental disorders. Dr. Osman has trained in Psychiatry in France and in Austin, Texas. Read more.
Clinically Reviewed By:
Josh Sprung, L.C.S.W.Board Certified Clinical Social Worker
Joshua Sprung serves as a Clinical Reviewer at Tennessee Detox Center, bringing a wealth of expertise to ensure exceptional patient care. Read More
-
UMR. (n.d.). About UMR. UMR. https://www.umr.com/about-umr
-
HealthCare.gov. (n.d.). Mental health & substance use disorder coverage. HealthCare.gov. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
-
MR. (n.d.). Member portal. UMR. https://www.umr.com/member
The Joint Commission – The Gold Seal of Approval® signifies that Tulip Hill Healthcare meets or exceeds rigorous national standards for patient care, safety, and quality.
LegitScript Certified – Confirms compliance with laws and standards for transparency and ethical marketing in addiction treatment.
BBB Accredited – Demonstrates Tulip Hill Healthcare’s commitment to ethical business practices and community trust.
Psychology Today Verified – Indicates a verified listing on Psychology Today for trustworthy treatment services.
HIPAA Compliant – Ensures patient information is protected under federal privacy regulations.
ASAM Member – Reflects a commitment to science-based addiction treatment as a member of the American Society of Addiction Medicine.
Nashville Chamber of Commerce Member – Signifies active engagement in community and regional development efforts.
CARF Accredited – Demonstrates that Tulip Hill Healthcare meets internationally recognized standards for quality, accountability, and service excellence in behavioral health care.
Did you know that your insurance plan may cover medical detox?
Supporting Families Through Recovery
What Our Patients Say: Stories of Hope and Recovery
Hear directly from those who have walked the path to recovery. Our patients’ stories highlight the compassionate care, effective programs, and life-changing support they’ve experienced. Let their journeys inspire you as you take your first steps toward healing.
